Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ligand Pharm (LGND)

Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,016,995
  • Shares Outstanding, K 19,294
  • Annual Sales, $ 167,130 K
  • Annual Income, $ -4,030 K
  • EBIT $ -29 M
  • EBITDA $ 6 M
  • 60-Month Beta 0.87
  • Price/Sales 11.94
  • Price/Cash Flow 64.39
  • Price/Book 2.51

Options Overview Details

View History
  • Implied Volatility 36.79% ( +1.08%)
  • Historical Volatility 34.48%
  • IV Percentile 5%
  • IV Rank 9.30%
  • IV High 65.30% on 04/08/25
  • IV Low 33.87% on 05/12/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 50
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 124
  • Open Int (30-Day) 403

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.50
  • Number of Estimates 3
  • High Estimate 0.75
  • Low Estimate 0.21
  • Prior Year 0.92
  • Growth Rate Est. (year over year) -45.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
99.24 +6.12%
on 05/08/25
112.55 -6.43%
on 04/29/25
+0.34 (+0.32%)
since 04/17/25
3-Month
93.58 +12.53%
on 04/09/25
125.17 -15.87%
on 03/03/25
-16.69 (-13.68%)
since 02/19/25
52-Week
77.43 +36.02%
on 06/10/24
129.90 -18.93%
on 11/07/24
+19.25 (+22.37%)
since 05/17/24

Most Recent Stories

More News
Ligand to Ring the Nasdaq Opening Bell on May 19, 2025

LGND : 105.31 (+0.74%)
Ligand: Q1 Earnings Snapshot

Ligand: Q1 Earnings Snapshot

LGND : 105.31 (+0.74%)
Ligand Reports First Quarter 2025 Financial Results

LGND : 105.31 (+0.74%)
Ligand to Participate in May Investor Conferences

LGND : 105.31 (+0.74%)
Ligand to Report First Quarter 2025 Financial Results on May 8, 2025

LGND : 105.31 (+0.74%)
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics

LGND : 105.31 (+0.74%)
CHRO : 1.0500 (+5.00%)
Ligand to Participate in March Investor Conferences

LGND : 105.31 (+0.74%)
Ligand: Q4 Earnings Snapshot

Ligand: Q4 Earnings Snapshot

LGND : 105.31 (+0.74%)
Ligand Reports Fourth Quarter and Full Year 2024 Financial Results

LGND : 105.31 (+0.74%)
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences

LGND : 105.31 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated...

See More

Key Turning Points

3rd Resistance Point 107.68
2nd Resistance Point 106.44
1st Resistance Point 105.49
Last Price 105.31
1st Support Level 103.29
2nd Support Level 102.05
3rd Support Level 101.10

See More

52-Week High 129.90
Fibonacci 61.8% 109.85
Last Price 105.31
Fibonacci 50% 103.66
Fibonacci 38.2% 97.47
52-Week Low 77.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar